T1 breast carcinoma in women 70 years of age and older may not require axillary lymph node dissection
| Autor: | Andrew Findley, Bruce J. Feigelson, Eric L. Saunders, Jose A. Acosta, Heather S. Feigelson |
|---|---|
| Rok vydání: | 1996 |
| Předmět: |
medicine.medical_specialty
medicine.medical_treatment Mammary gland Population Breast Neoplasms Cohort Studies Breast cancer medicine Humans education Aged Neoplasm Staging Retrospective Studies Aged 80 and over education.field_of_study business.industry Age Factors Axillary Lymph Node Dissection General Medicine medicine.disease Surgery Axilla medicine.anatomical_structure Lymph Node Excision Adenocarcinoma Female Lymphadenectomy business Breast carcinoma Follow-Up Studies |
| Zdroj: | The American Journal of Surgery. 172:487-490 |
| ISSN: | 0002-9610 |
| DOI: | 10.1016/s0002-9610(96)00249-8 |
| Popis: | Background The current trend in breast cancer treatment is toward breast conservation and selective use of axillary lymph node dissection. Patient eligiblity criteria for treatment without axillary dissection are evolving. Methods We retrospectively reviewed the tumor registry over a 10-year period at Naval Medical Center San Diego and included all women aged 70 and older with T1 breast carcinoma (n = 78). Data included tumor size, surgical therapy, postoperative therapy, recurrence, and survival. The women were divided into groups by the approach taken toward the axilla. Results No patient was given adjuvant chemotherapy. There were no axillary cancer recurrences in our patients. No statistically significant difference existed, regardless of the approach to the axilla, in recurrence or survival between groups. Conclusion Axillary dissection in this population did not influence postoperative treatment, decrease recurrence, or improve survival. Our study suggests breast cancer treatment in this populationshould not include axillary dissection. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect